Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 10, 2016, Pages 1398-1411

  Orci, Lorenzo A ^a   Gariani, Karim ^a   Oldani, Graziano ^a   Delaune, Vaihere ^a   Morel, Philippe ^a   Toso, Christian ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Aerobic Training; BMI; Liver Steatosis; Systematic Review; Weight Loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPID;

AEROBIC EXERCISE; BODY MASS; DIET; EFFECT SIZE; EXERCISE; HUMAN; LIFESTYLE MODIFICATION; LIPID ANALYSIS; META ANALYSIS; MULTICENTER STUDY (TOPIC); NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; REVIEW; SYSTEMATIC REVIEW; LIFESTYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; TREATMENT OUTCOME;

EXERCISE; HUMANS; LIFE STYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84991032538     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.04.036     Document Type: Review

References (61)

1. 1 Michelotti, G.A., Machado, M.V., Diehl, A.M., NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10 (2013), 656–665.
2. 2 Blachier, M., Leleu, H., Peck-Radosavljevic, M., et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58 (2013), 593–608.
3. 3 Lazo, M., Hernaez, R., Eberhardt, M.S., et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 178 (2013), 38–45.
4. 4 Zelber-Sagi, S., Nitzan-Kaluski, D., Halpern, Z., et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 26 (2006), 856–863.
5. 5 Jimba, S., Nakagami, T., Takahashi, M., et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Med 22 (2005), 1141–1145.
6. 6 Fan, J.G., Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastrotenterol Hepatol 28:Suppl 1 (2013), 11–17.
7. 7 Romeo, S., Kozlitina, J., Xing, C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature Genet 40 (2008), 1461–1465.
8. 8 Speliotes, E.K., Butler, J.L., Palmer, C.D., et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52 (2010), 904–912.
9. 9 Das, K., Das, K., Mukherjee, P.S., et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 51 (2010), 1593–1602.
10. 10 Chalasani, N., Younossi, Z., Lavine, J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
11. 11 Harrison, S.A., Fecht, W., Brunt, E.M., et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 49 (2009), 80–86.
12. 12 Nelson, M.E., Rejeski, W.J., Blair, S.N., et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 116 (2007), 1094–1105.
13. 13 Hupin, D., Roche, F., Gremeaux, V., et al. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged >/=60 years: a systematic review and meta-analysis. Br J Sports Med 49 (2015), 1262–1267.
14. 14 Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, 2009, e1000097.
15. 15 Higgins, J.P., Altman, D.G., Gotzsche, P.C., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J, 343, 2011, d5928.
16. 16 Antuna-Puente, B., Disse, E., Rabasa-Lhoret, R., et al. How can we measure insulin sensitivity/resistance?. Diabetes Metab 37 (2011), 179–188.
17. 17 Egger, M., Davey Smith, G., Schneider, M., et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315 (1997), 629–634.
18. 18 Keating, S.E., Hackett, D.A., Parker, H.M., et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol 63 (2015), 174–182.
19. 19 Al-Jiffri, O., Al-Sharif, F.M., Abd El-Kader, S.M., et al. Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. Afr Health Sci 13 (2013), 667–672.
20. 20 Bacchi, E., Negri, C., Targher, G., et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology 58 (2013), 1287–1295.
21. 21 de Piano, A., de Mello, M.T., Sanches, PdL., et al. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol 24 (2012), 1313–1324.
22. 22 Eckard, C., Cole, R., Lockwood, J., et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol 6 (2013), 249–259.
23. 23 Finucane, F.M., Sharp, S.J., Purslow, L.R., et al. The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia 53 (2010), 624–631.
24. 24 Hallsworth, K., Fattakhova, G., Hollingsworth, K.G., et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60 (2011), 1278–1283.
25. 25 Johnson, N.A., Sachinwalla, T., Walton, D.W., et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50 (2009), 1105–1112.
26. 26 Larson-Meyer, D.E., Newcomer, B.R., Heilbronn, L.K., et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 16 (2008), 1355–1362.
27. 27 Lazo, M., Solga, S.F., Horska, A., et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 33 (2010), 2156–2163.
28. 28 Lee, S., Bacha, F., Hannon, T., et al. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61 (2012), 2787–2795.
29. 29 Lee, S., Deldin, A.R., White, D., et al. Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab 305 (2013), E1222–E1229.
30. 30 Levinger, I., Goodman, C., Peake, J., et al. Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors. Diabetic Med 26 (2009), 220–227.
31. 31 Promrat, K., Kleiner, D.E., Niemeier, H.M., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51 (2010), 121–129.
32. 32 Pugh, C.J., Cuthbertson, D.J., Sprung, V.S., et al. Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab 305 (2013), E50–E58.
33. 33 Savoye, M., Caprio, S., Dziura, J., et al. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care 37 (2014), 317–324.
34. 34 Shah, K., Stufflebam, A., Hilton, T.N., et al. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity 17 (2009), 2162–2168.
35. 35 Shojaee-Moradie, F., Baynes, K.C., Pentecost, C., et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50 (2007), 404–413.
36. 36 Slentz, C.A., Bateman, L.A., Willis, L.H., et al. Effects of aerobic vs resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab 301 (2011), E1033–E1039.
37. 37 St George, A., Bauman, A., Johnston, A., et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50 (2009), 68–76.
38. 38 Sullivan, S., Kirk, E.P., Mittendorfer, B., et al. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55 (2012), 1738–1745.
39. 39 Valizadeh, R., Nikbakht, M., Davodi, M., et al. The effect of eight weeks elected aerobic exercise on the levels of (AST, ALT) enzymes of men patients with fat liver. Proced Soc Behav Sci, 2011, 3362–3365.
40. 40 Wang, C.L., Liang, L., Fu, J.F., et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol 14 (2008), 1598–1602.
41. 41 Wong, V.W., Chan, R.S., Wong, G.L., et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 59 (2013), 536–542.
42. 42 Zelber-Sagi, S., Buch, A., Webb, M., et al. The effect of resistance training on non-alcoholic fatty liver disease (NAFLD): a randomized clinical trial. World J Gastroenterol 20 (2014), 4382–4384.
43. 43 Straznicky, N.E., Lambert, E.A., Grima, M.T., et al. The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects. Diabetes Obes Metab 14 (2012), 139–148.
44. 44 Tamura, Y., Tanaka, Y., Sato, F., et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 90 (2005), 3191–3196.
45. 45 Thompson, D., Markovitch, D., Betts, J.A., et al. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. J Appl Physiol 108 (2010), 769–779.
46. 46 Fedewa, M.V., Gist, N.H., Evans, E.M., et al. Exercise and insulin resistance in youth: a meta-analysis. Pediatrics 133 (2014), e163–e174.
47. 47 Faraone, S.V., Interpreting estimates of treatment effects: implications for managed care. Pharma Therap 33 (2008), 700–711.
48. 48 Jaeschke, R., Singer, J., Guyatt, G.H., Measurement of health-status: ascertaining the minimal clinically important difference. Controlled Clin Trials 10 (1989), 407–415.
49. 49 Cohen, J., Statistical power analysis for the behavioral-sciences. 1988, Erlbaum Associates, Hillsdale.
50. 50 Higgins, J.P., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions. Version 5.1.0, 2011, Cochrane Collaboration Available from: www.cochrane-handbook.org.
51. 51 Norman, G.R., Sloan, J.A., Wyrwich, K.W., Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (2003), 582–592.
52. 52 Schwimmer, J.B., Middleton, M.S., Behling, C., et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61 (2015), 1887–1895.
53. 53 Noureddin, M., Lam, J., Peterson, M.R., et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58 (2013), 1930–1940.
54. 54 Patel, N.S., Doycheva, I., Peterson, M.R., et al. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13 (2015), 561–568 e1.
55. 55 Vos, M.B., Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?. Hepatology 61 (2015), 1779–1780.
56. 56 Berardis, S., Sokal, E., Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr 173 (2014), 131–139.
57. 57 Marzuillo, P., Grandone, A., Perrone, L., et al. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World J Gastroenterol 21 (2015), 6444–6450.
58. 58 Wardle, J., Brodersen, N.H., Cole, T.J., et al. Development of adiposity in adolescence: five year longitudinal study of an ethnically and socioeconomically diverse sample of young people in Britain. Br Med J 332 (2006), 1130–1135.
59. 59 Oh, S., Shida, T., Yamagishi, K., et al. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. Hepatology 61 (2015), 1205–1215.
60. 60 Unick, J.L., Beavers, D., Bond, D.S., et al. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med 126 (2013), 236–242 42 e1–e2.
61. 61 Kistler, K.D., Brunt, E.M., Clark, J.M., et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 106 (2011), 460–468.